Corpus Intelligence IC Memo — MASSENA MEMORIAL HOSPITAL 2026-04-26 15:27 UTC
IC Memo — MASSENA MEMORIAL HOSPITAL
Investment Committee Memorandum | NY | 25 beds | Grade C | EBITDA uplift $3.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MASSENA MEMORIAL HOSPITAL

CCN 330223 | ST. LAWRENCE, NY | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MASSENA MEMORIAL HOSPITAL is a 25-bed suburban community hospital in ST. LAWRENCE, NY with $48.4M in net patient revenue and a -14.4% operating margin. The hospital serves a payer mix of 34.7% Medicare, 2.7% Medicaid, and 62.6% commercial.

Thesis: Turnaround. Our ML models identify $3.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -14.4% to -7.0% (+736bps).

Net Revenue HCRIS$48.4M
Current EBITDA COMPUTED$-7.0M
Operating Margin COMPUTED-14.4%
Occupancy HCRIS55.1%
Revenue / Bed COMPUTED$1.9M
Net-to-Gross HCRIS35.4%
Distress Probability ML46.2%

2. Market Context & Competitive Position

196
NY Hospitals
-17.5%
State Median Margin
30
Comparable Hospitals

NY has 196 Medicare-certified hospitals with a median operating margin of -17.5%. The target's margin of -14.4% places it above the state median. Among 30 size-comparable peers (12-50 beds), the median margin is -17.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 30 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MASSENA MEMORIAL HOSPITAL (Target)NY25$48.4M-14.4%
NEW YORK EYE AND EAR INFIRMARYNY15$112.8M-28.0%
CLAXTON HEPBURN MEDICAL CENTERNY38$106.9M-16.0%
ALICE HYDE MEDICAL CENTERNY40$79.7M-29.4%
LEWIS COUNTY GENERAL HOSPITALNY25$70.3M-17.6%
JONES MEMORIAL HOSPITALNY49$60.7M-22.3%
CARTHAGE AREA HOSPITALNY25$59.4M-12.3%
WYOMING COUNTY COMMUNITY HOSPINY47$58.1M-42.1%
SUNNYVIEW HOSPITAL AND REHABILNY17$56.6M-9.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.0M+210bp18mo
Cost to Collect4.5%2.5%$968K+200bp12mo
Denial Rate Reduction12.0%6.5%$958K+198bp12mo
A/R Days Reduction5200.0%3800.0%$589K+122bp9mo
Clean Claim Rate88.0%96.0%$31K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.0M
Cost to Collect
$968K
Denial Rate Reduction
$958K
A/R Days Reduction
$589K
Clean Claim Rate
$31K
Total EBITDA Uplift$3.6M
Current EBITDA$-7.0M
+ RCM Uplift+$3.6M
Pro Forma EBITDA$-3.4M
Current Margin-14.4%
Pro Forma Margin-7.0%
WC Released (1x)$1.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-10.7M$-10.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-10.7M$-14.7M0.00x-100.0%
Bull Case9.0x11.0x$-9.6M$-6.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-9.6M$-9.9M0.00x-100.0%
Bear Case11.0x10.0x$-11.8M$-24.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-11.8M$-30.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 30 hospitals with 12-50 beds
  • Same-state prioritization (n=31)
  • Comp margins: P25=-28.0% / P50=-17.8% / P75=-9.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.